Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements.
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 50 (6) , PL25-PL30
- https://doi.org/10.1016/0024-3205(92)90382-y
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pharmacology of saccadic eye movements in manPsychopharmacology, 1991
- Pharmacology of saccadic eye movements in manPsychopharmacology, 1991
- Intravenous alprazolam challenge in normal subjectsPsychopharmacology, 1989
- The effect of neurotensin, TRH and the δ-opioid receptor antagonist ICI 174864 on alcohol-induced narcosis in ratsBrain Research, 1987
- Benzodiazepine Sensitivity in Normal Human SubjectsArchives of General Psychiatry, 1986
- Chlordiazepoxide displaces thyrotropin-releasing hormone (TRH) bindingEuropean Journal of Pharmacology, 1984
- Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized ratNeuropharmacology, 1984
- Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance.British Journal of Clinical Pharmacology, 1984
- Benzodiazepines compete for thyrotropin-releasing hormone receptor binding: Micromolar potency in rat pituitary, retina and amygdalaNeuroscience Letters, 1983
- Quantitative measurement of saccade amplitude, duration, and velocityNeurology, 1975